BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 7.22% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 7.19% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 4.59% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 4.49% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 4.23% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 3.67% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.55% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.44% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 3.16% |
| 207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 3.16% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.03% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 2.77% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.74% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 2.61% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.57% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.29% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.28% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.18% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.98% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 1.95% |